MedTrace Logo

Adhesive Materials for Continuous Glucose Monitoring Systems

NCT03340467 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-08-19

No results posted yet for this study

Summary

Within the present study 4 different band-aid/adhesive combinations will be tested in patients with type 1 diabetes and type 2 diabetes with regard to adherence to the body and allergic potential. The study period is set to 21 days following adhesive material placement to cover the maximum expected wear-time of the novel CGM system (14 days) plus an additional seven days to ensure that adhesive material is tested for a sufficient time-period and differences in adhesion can clearly be observed.

Conditions

Interventions

DEVICE

CGM patch

Patient receives four CGM patches.

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Metronom Health

    lead INDUSTRY

Principal Investigators

  • Julia Mader,, Ass Prof · Medical University of Graz

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2018-09-30
Completion
2018-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340467 on ClinicalTrials.gov